Last reviewed · How we verify

NCT04810923

Application of Injectable Platelet-Rich Fibrin for the Treatment of Temporomandibular Joint Osteoarthritis

Completed NA Last updated 23 March 2021
What this trial tests

NA trial testing i-PRF in Osteoarthritis in 36 participants. Completed in 2 December 2019.

Timeline
2 April 2019
Primary endpoint
2 December 2019
2 December 2019

Quick facts

Lead sponsorEge University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment36
Start date2 April 2019
Primary completion2 December 2019
Estimated completion2 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

Adults 18 to 65, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The authors designed a randomized, controlled, double-blind clinical trial after the ethical approval by the University Ethics Committee. The patients with temporomandibular joint osteoarthritis (TMJ-OA) randomly assigned one of the two treatment groups: intra-articular injection of injectable platelet-rich fibrin (i-PRF) after arthrocentesis procedure as i-PRF group and arthrocentesis procedure alone as control group. The primary outcome variable was pain levels at preoperatively, and postoperatively at 1st, 2nd, 3rd, 6th and 12th month. The secondary outcome variables included maximum mouth opening (MMO), lateral and protrusive movements.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evolution and mechanistic insights of platelet-derived products in temporomandibular joint regeneration.
    Lin C, Jin Y, Li D, Yang Q, et al · · 2026 · PMID 41646866 · DOI 10.3389/fcell.2026.1776592

Verify or expand the search:

Other trials of i-PRF

Trials testing the same drug.

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04810923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing